[HTML][HTML] Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities

KJ Napier, M Scheerer, S Misra - World journal of gastrointestinal …, 2014 - ncbi.nlm.nih.gov
Esophageal cancer is a serious malignancy with regards to mortality and prognosis. It is a
growing health concern that is expected to increase in incidence over the next 10 years …

Epidemiology of Barrett's esophagus and esophageal adenocarcinoma

TM Runge, JA Abrams… - Gastroenterology Clinics, 2015 - gastro.theclinics.com
Barrett's esophagus (BE) is a condition in which the typical squamous epithelium of the
esophageal mucosa is replaced with columnar intestinal epithelium. 1, 2 BE is a known …

[图书][B] WHO classification of tumours of the digestive system.

FT Bosman, F Carneiro, RH Hruban, ND Theise - 2010 - cabdirect.org
This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

S Bhat, HG Coleman, F Yousef… - Journal of the …, 2011 - academic.oup.com
Background Barrett's esophagus (BE) is a premalignant lesion that predisposes to
esophageal adenocarcinoma. However, the reported incidence of esophageal …

[PDF][PDF] Epidemiologic risk factors for esophageal cancer development

WM Mao, WH Zheng, ZQ Ling - Asian Pac J Cancer Prev, 2011 - researchgate.net
In retrospective studies of esophageal cancer (EC), cigarettes and hookah smoking, nass
use (a chewing tobacco product), opium consumption, hot tea drinking, poor oral health, low …

Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia

R Anaparthy, S Gaddam, V Kanakadandi… - Clinical …, 2013 - Elsevier
Background & Aims It is not clear whether length of Barrett's esophagus (BE) is a risk factor
for high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) in patients with …

[HTML][HTML] Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus

P Gatenby, C Caygill, C Wall… - World journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To investigate the lifetime risk of development of esophageal adenocarcinoma and/or
high-grade dysplasia in patients diagnosed with Barrett's esophagus. METHODS: Data were …

Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA)

M Rugge, G Zaninotto, P Parente, L Zanatta… - Annals of …, 2012 - journals.lww.com
Objective: To establish the incidence and risk factors for progression to high-grade
intraepithelial neoplasia (HG-IEN) or Barrett's esophageal adenocarcinoma (BAc) in a …

Radiofrequency ablation for long-and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study

PS Dulai, H Pohl, JM Levenick, SR Gordon… - Gastrointestinal …, 2013 - Elsevier
BACKGROUND: The safety, efficacy, and durability of radiofrequency ablation (RFA), with or
without EMR, have been established for long-segment Barrett's esophagus (LSBE). Ablating …

Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review

JM Barbiere, G Lyratzopoulos - Gastroenterology, 2009 - Elsevier
Screening interventions for Barrett's esophagus (BE) are appealing, but there is little
supporting evidence. We reviewed health economics studies about BE endoscopic …